The Elton John AIDS Foundation is pleased to hear about the FDA approval of lenacapavir as a new and extremely effective prevention technology for HIV transmission.
Lenacapavir represents a breakthrough prevention method that will fundamentally bend the curve of new HIV infections with a twice-yearly injection that has been proven to reduce HIV risk by at least 96%.
We are already collaborating with other organizations to ensure the successful introduction of lenacapavir in high-risk communities when it becomes available early next year, doubling down on our sustainable investments that make ending AIDS a near-term reality.
We are committed to supporting and optimizing the rollout of lenacapavir ensuring this revolutionary treatment reaches those who need it most urgently—this is a historic opportunity to change the trajectory of AIDS forever.
